REFERENCES
- Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagu-lation and fibrinolysis associated with cardio-pulmonary bypass during open heart surgery. J Cardiothorac Anesth 1989; 3: 181–8.
- Pixley RA, Cassello A, De La Cadena RA, Kaufman N, Colman RW. Effect of heparin on activation of factor XII and the contact system in plasma. Thromb Haemost 1991; 66: 540–7.
- Cochrane CG, Griffin JH. The biochemistry and pathophysiology of the contact system of plasma. Adv Immunol 1982; 33: 242–97.
- Gallimore MJ, Heller W, Fuhrer G, Wendel H, Klaffschenkel R, Hoffmeister HE. Contact acti-vation, heparins and cardiopulmonary bypass [letter]. Thromb Haemost 1993; 69: 92–3.
- Bachman R, McKenna R, Cole ER, Maiafi Hi. The hemostatic mechanism after open-heart extracor-poreal circulation. J Thorac Cardiovasc Surg 1975; 70: 76–85.
- Stibbe J, Kluft C, Brommer EJ, Gomes M, De Jong DS, Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open heart sur-gery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest 1984; 14: 375–82.
- Tanaka K, Takao M, Yada I, Yasa H, Kusagawa M, Deguchi K. Alternations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 1989; 3: 181–8.
- Holloway DS, Sumtnaria L, Sandesara J, Vagher JP, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopul- monary bypass patients. Thromb Haemost 1988; 59: 62–7.
- Kalter RDC, Saul CM, Wetstein L, Sorino C, Reiss RF. Cardiopulmonary bypass: associated hemostatic abnormalities. J Thorac Cardiovasc Surg 1979; 77: 427–35.
- Pickering NJ, Brody JI, Fink GB, Finnegan JO, Ablaza S. The behavior of antithrombin III, alpha 2-macroblobulin, and alpha 1-antitrypsin during cardiopulmonary bypass. Am J Clin Pathol 1983; 80: 459–64.
- Kongsgard UE, Smith-Erichsen N, Geiran 0, Bjornskau L. Changes in the coagulation and fibrinolytic systems during and after cardiopulmon-ary bypass surgery. J Thorac Cardiovasc Surg 1989; 37: 158–62.
- Umlas J. Fibrinolysis and disseminated intravascu-lar coagulation in open heart surgery. Transfusion 1976; 16: 460–3.
- Wolk LA, Wilson RF, Burdick M, Selik N, Brown J, Starrico A, Mammen EF. Changes in antithrombin, an tiplasmin, and plasminogen during and after cardiopulmonary bypass. Am Surg 1985; 51: 309–13.
- Aasen AO, Kierulf P, Stromme JH. Metho-dological considerations on chromogenic peptide substrates assays and application on automated analyzers. Acta Chir Scand 1982; Suppl: 17–23.
- Kongsgkd UE, Smith-Erichsen N, Geiran 0, Amundsen E, Mollnes TE, Garred P. Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery. Acta Anaesthesiol Scand 1989; 33: 343–7.
- Seghaye MC, Duchateau J, Grabitz RG, Faymonville ML, Messmer BJ, Buro-Raths-mann K, et at Complement activation during cardio-pulmonary bypass in infants and children. J Thorac Cardiovasc Surg 1993; 106: 978–87.
- Kongsgard UE, Smith-Erichsen N, Hysing E, Tollofsrud S, Seem E, Geiran 0, et al. Haemodynamic effects of heparin during coronary bypass surgery. Acta Anaesthesiol Scand 1991; 35: 758–61.
- Aasen AO. The proenzyme functional inhibition index. A new parameter for the evaluation of the severely injured and septic patient. Acta Chir Scand 1985; 522 Suppl: 211–33.